| Literature DB >> 33861392 |
Marianna Santonastaso1, Filomena Mottola2, Concetta Iovine2, Nicola Colacurci1, Lucia Rocco3.
Abstract
Cryopreservation causes decreased sperm fertility potential due to reactive oxygen species (ROS) production and physical-chemical damage, resulting in reduced sperm viability and motility. The addition of antioxidants to freezing media could protect sperm from cryo-damage, counteracting the harmful effects of ROS. The aim of this study was to assess the effects of curcumin supplementation in freezing medium on preventing cryo-damage in human semen. Semen samples collected from fertile men were cryopreserved in freezing medium supplemented with different concentrations of curcumin (2.5, 5, 10, and 20 μM). After freezing-thawing, sperm parameters, DNA fragmentation, intracellular ROS, and glutathione peroxidase 4 (GPX4) gene expression were evaluated. Supplementation with 20 μM curcumin in freezing medium caused increases in progressive and nonprogressive motility and significant reductions in intracellular ROS and DNA fragmentation in frozen-thawed sperm cells. Following cryopreservation, GPX4 mRNA expression was significantly upregulated in thawed semen supplemented with 20 μM curcumin compared to the control. The results showed that curcumin supplementation in freezing medium was protective against human sperm parameters and sperm DNA, counteracting oxidative damage induced by the freeze-thaw process.Entities:
Keywords: Curcumin; Glutathione peroxidase 4; Oxidative stress; Sperm DNA fragmentation; Sperm cryopreservation; Sperm quality
Mesh:
Substances:
Year: 2021 PMID: 33861392 PMCID: PMC8523395 DOI: 10.1007/s43032-021-00572-9
Source DB: PubMed Journal: Reprod Sci ISSN: 1933-7191 Impact factor: 3.060
Parameters of semen selected for the study (n = 60). Sperm parameters were expressed as mean ± SD
| Sperm parameters | Mean ± SD |
|---|---|
| Semen volume (mL) | 3.16 ± 1.43 |
| Sperm concentration (× 106 sperm/mL) | 65.36 ± 23.94 |
| Motility (%) | |
| Progressive | 49.67 ± 4.66 |
| Non-progressive | 27.0 ± 8.51 |
| Immotile | 23.33 ± 11.44 |
| Normal morphology (%) | 24.42 ± 8.62 |
| Viability (%) | 78.75 ± 10.18 |
Real-time q-PCR primers. F: forward primer; R: reverse primer; GPX4: glutathione peroxidase 4; ß-ACT: ß-actin
| Gene | Primer sequence (5′ to 3′) |
|---|---|
F: TCA GCA AGA TCT GCG TGA AC R: CCG GAT GCC ATA GTC AGG AT | |
F: GGA CTT CGA GCA AGA GAT GG R: AGC ACT GTG TTG GCG TAC AG |
Effect of curcumin concentrations (2.5, 5, 10 and 20 μM) added to freezing medium on progressive motility (PR) and total motility (progressive + nonprogressive (NP)) and viability. The values were expressed as mean ± SD. *p ≤ 0.05
| Treatments | Progressive motility (PR) (%) | Total motility (PR+ NP) (%) | Viability (%) |
|---|---|---|---|
| Control (freezing medium) | 28.15 ± 3.50 | 42.59 ± 4.45 | 50.57± 10.28 |
| 2.5 μM Curcumin (freezing medium + curcumin 2.5 μM) | 27.78 ± 5.00 | 40.35 ± 2.57 | 51.23± 8.56 |
| 5 μM Curcumin (freezing medium + curcumin 5 μM) | 26.50 ± 4.05 | 39.75± 5.65 | 49.76± 9.87 |
| 10 μM Curcumin (freezing medium + curcumin 10 μM) | 35.65 ± 3.12 | 51.71 ± 5.36 | 54.78 ± 11.23 |
| 20 μM Curcumin (freezing medium + curcumin 20 μM) | 47.20 ± 5.80* | 65.00 ± 3.73* | 56. 35 ± 12.03 |
Fig. 1Intracellular ROS (green cell) in human sperm cells analysed by fluorescence microscopy using the DCFH2-DA probe in different treatment groups: a vehicle control; b 2.5 μM curcumin-treated group; c 5 μM curcumin-treated group; d 10 μM curcumin-treated group; 20 μM curcumin-treated group
Fig. 2Percentage of intracellular ROS (ordinate) in human sperm cells in the different treatment groups (n = 12) (abscissa) after the thawing procedure. The black bars are vehicle controls (VC); the dark grey bars are the 2.5 μM curcumin-treated group (curcumin 2.5); the light grey bars are the 5 μM curcumin-treated group (Curcumin 5); the striped bars are the 10 μM curcumin-treated group (Curcumin 10); and the dotted bars are the 20 μM curcumin-treated group (Curcumin 20). The error bars represent ± standard deviation (SD). *p ≤ 0.05
Fig. 3Human sperm DNA fragmentation as analysed by a TUNEL assay in the different treatment groups: a vehicle control; b 2.5 μM curcumin-treated group; c 5 μM curcumin-treated group; d 10 μM curcumin-treated group; 20 μM curcumin-treated group
Fig. 4DNA fragmentation index (ordinate) in human sperm cells in different treatment groups (n = 12) (abscissa) after the thawing procedure. The black bars are vehicle controls (VC); the dark grey bars are the 2.5 μM curcumin-treated group (Curcumin 2.5); the light grey bars are the 5 μM curcumin-treated group (Curcumin 5); the striped bars are the 10 μM curcumin-treated group (Curcumin 10); and the dotted bars are the 20 μM curcumin-treated group (Curcumin 20). The error bars represent ± standard deviation (SD). *p ≤ 0.05
Fig. 5RT-qPCR analysis of GPX4 (ordinate) in human spermatozoa in different treatment groups (n = 12) (abscissa) after the thawing procedure. The black bars are vehicle controls (VC); the dark grey bars are the 2.5 μM curcumin-treated group (Curcumin 2.5); the light grey bars are the 5 μM curcumin-treated group (Curcumin 5); the striped bars are the 10 μM curcumin-treated group (Curcumin 10); and the dotted bars are the 20 μM curcumin-treated group (Curcumin 20). The error bars represent ± standard deviation (SD). *p ≤ 0.05